Short-term Mortality Prediction by the SOFA Score in Acute Decompensated Heart Failure
Short-term Mortality and Readmission Rate Prediction by the Sequential Organ Failure Assessment Score in Acute Decompensated Heart Failure
1 other identifier
observational
216
1 country
1
Brief Summary
Data on the use of sequential organ failure assessment (SOFA) in patients with cardiovascular disease are increasing. Several studies demonstrated that the SOFA score can identify short-term mortality in patients with acute decompensated heart failure (ADHF). This study was conducted to determine the prognostic value of the admission SOFA score in patients hospitalised for ADHF and to assess its ability in predicting the 30-day readmission rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedFirst Submitted
Initial submission to the registry
March 30, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedApril 9, 2024
April 1, 2024
1.2 years
March 30, 2024
April 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality
The sequential organ failure assessment (SOFA) score was used to assess the relation to the all cause mortality of the patient with acute decompensated heart failure. Higher SOFA score is correlated with higher in-hospital mortality rate and 30-day mortality regardless of age, gender, or other comorbidities.
Within 30 days from the day of hospitalization
Secondary Outcomes (1)
Re-admission rate
Within 30 days
Eligibility Criteria
This was a single-centre, prospective study conducted from July 2022 to August 2023 at Hanoi Heart Hospital (Hanoi, Vietnam).
You may qualify if:
- All patients over 18 years old who were hospitalised for acute heart failure were included (either new-onset acute heart failure or ADHF).
You may not qualify if:
- Patients with septic shock or pulmonary infarction were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hanoi Heart Hospital
Hanoi, Hoan Kiem, 110000, Vietnam
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2024
First Posted
April 9, 2024
Study Start
July 1, 2022
Primary Completion
August 31, 2023
Study Completion
August 31, 2023
Last Updated
April 9, 2024
Record last verified: 2024-04